106. What Midlife Women Need to Know About Psychedelics:…

About this episode

This is a conversation that deserves more nuance than a seven-second social media clip. Victoria sits down with Linden Schaffer, psychedelic wellness educator, author, and founder of Reveal, for an honest, evidence-informed discussion on what psychedelics actually are, what the current research says, and how midlife women can think critically about whether any of this belongs in their own wellness journey. Linden is not a hype machine. She has spent more than two decades at the intersection of wellness, transformation, and psychedelic harm reduction, and she brings that same rigor to this conversation. What emerges is a grounded, thoughtful exchange that honors both the science and the complexity, including the parts the headlines leave out. What You'll Hear in This Episode A plain-language overview of psychedelics, from classic compounds like psilocybin and LSD to lesser-known substances like ibogaine and MDMA The history of psychedelic research, from Albert Hofmann's synthesis of LSD in the 1940s to the Nixon-era criminalization that halted decades of promising clinical work Why the pandemic became an inflection point for renewed interest in these compounds The current legal landscape in the U.S., including Oregon and Colorado's regulated frameworks, decriminalization efforts in cities nationwide, and what federal scheduling still means for your personal risk profile How midlife women in particular are being underserved by a medical system that too often defaults to SSRIs without exploring root causes What microdosing is, how it differs from larger dose experiences, and why Linden chose it herself when perimenopause symptoms arrived before she could get a hormone therapy appointment The critical importance of preparation, integration, and what Linden calls the "wellness toolbox" — and why the compound alone is never the whole story How to evaluate a retreat, a facilitator, or an experience using Linden's five-part Reveal Method: screening, set, setting, support, and sustainability The intersection of psychedelics and GLP-1 medications, including what is and is not yet known about interactions and timing The ethical and cultural concerns around ibogaine, biopiracy, and what happens when pharmaceutical companies enter sacred spaces Red flags to watch for in a commercializing marketplace, from Instagram-polished retreat brochures to untested compounds sold in smoke shops A Note from Victoria As a licensed pharmacist and certified menopause practitioner, I brought a lot of questions to this conversation, including ones about drug interactions, scheduling law, and what informed consent actually looks like in practice. Linden met every one of them with honesty. This episode is not medical advice, and we are both clear on that throughout. But it is the kind of informed, grounded conversation that I believe midlife women deserve access to, especially as the research and policy landscape continues to shift. Resources and Links Linden Schaffer's website and one-to-one coaching: revealcommunity.world Reveal Community on TikTok (live education, Q&A, and community building) Linden's online courses: microdosing and large-dose experience preparation Global Psychedelic Society MAPS (Multidisciplinary Association for Psychedelic Studies) Let's Keep the Conversation Going If this episode resonated with you, please rate, review, and share it with someone who needs to hear it. Subscribe to Women Mastering Midlife on your favorite podcast platform to receive weekly conversations that help you navigate perimenopause, menopause, and midlife health with clarity and confidence. Join the Women Mastering Midlife Community and let's grow stronger together. Get your FREE guides HERE: www.womenmasteringmidlife.com/freeguides Share your thoughts and stories on our social channels and tag us @misvictoriabyrd. Let's rewrite the narrative together! Find more information on our website: www.womenmasteringmidlife.com Book a FREE 1:1 discovery call to lear